-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Bionik Laboratories Corp. annual/quarterly Amortization of Intangible Assets history and growth rate from 2015 to 2022.
- Bionik Laboratories Corp. Amortization of Intangible Assets for the quarter ending March 31, 2022 was $295.000, a 100% decline year-over-year.
- Bionik Laboratories Corp. Amortization of Intangible Assets for the twelve months ending March 31, 2022 was $1.58M, a 3.87% increase year-over-year.
- Bionik Laboratories Corp. annual Amortization of Intangible Assets for 2022 was $1.58M, unchanged from 2021.
- Bionik Laboratories Corp. annual Amortization of Intangible Assets for 2021 was $1.58M, a 3.87% increase from 2020.
- Bionik Laboratories Corp. annual Amortization of Intangible Assets for 2020 was $1.52M, a 6.6% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)